ANVISA registration

BIOCLIN FAST COVID-19 anti-RBD

Registration 10269360342. CORONAVÍRUS

Registration details

Registration number10269360342
Application number25351172215202113
Technical nameCORONAVÍRUS
Risk classIII
Published on12/04/2021
ValidityValid until 12/04/2031

Registration holder

Legal nameQUIBASA - QUIMICA BASICA LTDA
CNPJ19.400.787/0001-07

Manufacturer

  • QUIBASA QUÍMICA BÁSICA LTDA BRASIL

Other registrations held by QUIBASA - QUIMICA BASICA LTDAview all

ALFA 1 GLICOPROTEINA ACIDA

10269360061

ANTI ESTREPTOLISINA O

10269360067

URÉIA UV

10269360068

IMUNOGLOBULINA A

10269360069

PROTEINA C REATIVA

10269360070

CK-MB UV

10269360073

Source: ANVISA

Source: ANVISA open data, medical device file, updated daily. The public database provides registration validity, rather than registration status: this registration may have been cancelled before its expiry date without this being shown here. Before making purchasing, import or marketing decisions, check the ANVISA search portal.

Next step

Medical device registration with ANVISA

HSC manages the process from risk classification to liaising with the regulator, in Brazil and more than 40 other countries.

Speak to a specialist